Browse by Journal Title

2021

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Borchmann, P. and Plütschow, A. and Kobe, C. and Greil, R. and Meissner, J. and Topp, M.S. and Ostermann, H. and Dierlamm, J. and Mohm, J. and Thiemer, J. and Sökler, M. and Kerkhoff, A. and Ahlborn, M. and Halbsguth, T.V. and Martin, S. and Keller, U. and Balabanov, S. and Pabst, T. and Vogelhuber, M. and Hüttmann, A. and Wilhelm, M. and Zijlstra, J.M. and Moccia, A. and Kuhnert, G. and Bröckelmann, P.J. and von Tresckow, B. and Fuchs, M. and Klimm, B. and Rosenwald, A. and Eich, H. and Baues, C. and Marnitz, S. and Hallek, M. and Diehl, V. and Dietlein, M. and Engert, A.
Lancet Oncology 22 (2): 223-234. February 2021

2019

Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
Weller, J. and Tzaridis, T. and Mack, F. and Steinbach, J.P. and Schlegel, U. and Hau, P. and Krex, D. and Grauer, O. and Goldbrunner, R. and Bähr, O. and Uhl, M. and Seidel, C. and Tabatabai, G. and Brehmer, S. and Bullinger, L. and Galldiks, N. and Schaub, C. and Kebir, S. and Stummer, W. and Simon, M. and Fimmers, R. and Coch, C. and Glas, M. and Herrlinger, U. and Schäfer, N.
Lancet Oncology 20 (10): 1444-1453. October 2019

2017

Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
Eichenauer, D.A. and Plütschow, A. and Kreissl, S. and Sökler, M. and Hellmuth, J.C. and Meissner, J. and Mathas, S. and Topp, M.S. and Behringer, K. and Klapper, W. and Kuhnert, G. and Dietlein, M. and Kobe, C. and Fuchs, M. and Diehl, V. and Engert, A. and Borchmann, P.
Lancet Oncology 18 (12): 1680-1687. December 2017

2013

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.
Nordlinger, B. and Sorbye, H. and Glimelius, B. and Poston, G.J. and Schlag, P.M. and Rougier, P. and Bechstein, W.O. and Primrose, J.N. and Walpole, E.T. and Finch-Jones, M. and Jaeck, D. and Mirza, D. and Parks, R.W. and Mauer, M. and Tanis, E. and Van Cutsem, E. and Scheithauer, W. and Gruenberger, T.
Lancet Oncology 14 (12): 1208-1215. November 2013

2002

Hyperthermia in combined treatment of cancer.
Wust, P. and Hildebrandt, B. and Sreenivasa, G. and Rau, B. and Gellermann, J. and Riess, H. and Felix, R. and Schlag, P.M.
Lancet Oncology 3 (8): 487-497. August 2002